Seelos Therapeutics
SEEL
$0.29
Share price
-1.73%
Change (1 day)
-65.18%
Change (1 year)
Categories
Operating Margin for Seelos Therapeutics (SEEL)
Operating Margin as of May 2024 (TTM): -13,568.00%
According to Seelos Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -13,568.00%. At the end of 2019 the company had an Operating Margin of -13,568.00%.
Operating Margin history for Seelos Therapeutics from 2002 to 2019
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2019 | -13,568.00% | |
| 2016 | -128.98% | -67.19% |
| 2015 | -393.12% | 61.94% |
| 2014 | -242.76% | -61.59% |
| 2013 | -632.02% | 112.39% |
| 2012 | -297.58% | -32.64% |
| 2011 | -441.76% | -25.55% |
| 2010 | -593.40% | -45.67% |
| 2009 | -1,092.25% | 965.19% |
| 2008 | -102.54% | -86.42% |
| 2007 | -755.15% | 63.73% |
| 2006 | -461.22% | -30.51% |
| 2005 | -663.71% | -86.42% |
| 2004 | -4,887.09% | -69.01% |
| 2003 | -15,771.47% | -16.27% |
| 2002 | -18,837.09% | -25.44% |
| 2001 | -25,266.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.